Introduction The National Institute for Materials Science (NIMS) is a renowned scientific research institution in Japan and operates as an Independent Administrative Institution. With its extensive resources and expertise, NIMS has established itself as a leading center for materials science research in the country. |
Target |
Mechanism Collagen I modulators [+1] |
Active Org. |
Originator Org.- |
Active Indication |
Inactive Indication |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org. |
Originator Org.- |
Active Indication |
Inactive Indication |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Start Date14 Nov 2018 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Cocoa flavanols | Peripheral arterial occlusive disease More | Pending |
Sangstat | Anemia, Sickle Cell More | Pending |
Dextrothyroxine Sodium ( THR-α ) | Myocardial Infarction More | Pending |
2-Hydroxybenzylamine | Hypercholesterolemia More | Pending |
[68Ga]CBP8 ( Collagen I ) | Lung Cancer More | Pending |